Kjell Öberg
Professor emeritus at Department of Medical Sciences; Endocrine Tumour Biology
- Mobile phone:
- +46 70 425 06 88
- E-mail:
- kjell.oberg@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 UPPSALA
Biography
Dr. Kjell Öberg is Professor of Endocrine Oncology at the Medical Faculty of Uppsala University. He was the former head of the Department of Endocrine Oncology, University Hospital, and he is a specialist in endocrinology and internal medicine. He founded the Dept. of Endocrine Oncology at Uppsala University Hospital and has 30 years experience in the field of neuroendocrine tumors. Between 1986 and 1992 he was clinical associate director of the Ludwig Institute for Cancer Research. From 1998 to 2002 he was chairman of the Department of Medical Sciences at the Medical Faculty of Uppsala University. Since July 2002 until June 2008 he has been the Dean of the Medical Faculty. He is the chairman of Centre of Excellence of Endocrine Tumors and Vice chairman of the Department of Endocrine Oncology, University Hospital, Uppsala. Currently Adjunct Professor of Surgery at Vanderbilt University, Nashville, US.
Dr. Öberg was one of the founders and coordinator of the European Neuroendocrine Tumor Network (ENET) 1995-2000 and was past chairman of the Nordic Neuroendocrine Tumour Group. He has pioneered the treatment of carcinoid tumor patients with interferon and somatostatin analogues and developed assays for tumor markers such as Chromogranin A and radiological procedures including specialized PET scans.
In 1988 he was the first to describe a genetic deletion in multiple endocrine neoplasia Type 1 (MEN1). Dr Öberg has given many hundreds of presentations at international meetings and published more than 500 papers within his research field, H-factor 64 and more than 12,000 citations. In addition he is the author of numerous chapters on Carcinoid tumors in several international textbooks including William’s Textbook of Endocrinology, Leslie de Groot’s Textbook of Endocrinology, Clinical Endocrinology and Fordtran’s Textbook of Gastroenterology. Dr. Öberg is Editor-in Chief of World Journal of Gastroenterolgy (WJG).
In 1991 Dr. Öberg received the European Interferon Research reward. In 2003 he received the award “Eminent Scientist Year 2003” by the International Research Promotion Council (IRPC) and World Scientist Forum and in 2004 he was awarded the European Gold Medal in Endocrinology from the English Endocrine Society. In November 2006 he received the Harry Boström Award Lecture at Swedish Medical Society. The University Hospital Clinical Research Award in 2011.
Dr. Öberg is a member of the Royal Society of Sciences, member of Swedish Society of Medical Research, Honorary member of Finnish Oncology Society, Finnish Endocrine Society and Honorary member of Spanish Neuroendocrine NET-work. Dr. Öberg is Chairman Elect of ENETS and also a member of NANETS Advisory Board as well as several other national and international research and scientific boards and many scientific journal review boards.

Publications
Recent publications
-
The NETest: A Multigene Liquid Biopsy for Diagnosis and Management of Neuroendocrine Tumors
Part of Neuroendocrine Tumours Diagnosis and Management, p. 81-102, Springer, 2024
-
Societies and Guidelines for Neuroendocrine Tumors
Part of Neuroendocrine Tumours Diagnosis and Management, p. 677-682, Springer, 2024
-
Update of Neuroendocrine Tumors, Diagnosis, and Management
Part of Neuroendocrine Tumours, p. 175-183, Springer, 2024
-
Part of Journal of Clinical Medicine, 2022
- DOI for A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires
- Download full text (pdf) of A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires
-
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
Part of Journal of neuroendocrinology, 2022
- DOI for ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
- Download full text (pdf) of ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
All publications
Articles in journal
-
Part of Journal of Clinical Medicine, 2022
- DOI for A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires
- Download full text (pdf) of A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires
-
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
Part of Journal of neuroendocrinology, 2022
- DOI for ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
- Download full text (pdf) of ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
-
Part of Neuroendocrinology, p. 298-309, 2022
- DOI for Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study
- Download full text (pdf) of Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study
-
Part of World Journal of Gastroenterology, p. 976-989, 2021
-
Cardiac Imaging in Carcinoid Heart Disease
Part of JACC Cardiovascular Imaging, p. 2240-2253, 2021
-
Part of Annals of Oncology, p. 1425-1433, 2021
-
Part of Annals of Surgical Oncology, p. 7506-7517, 2021
-
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
Part of Journal of Nuclear Medicine, p. 1712-1718, 2021
- DOI for Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
- Download full text (pdf) of Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
-
Part of European Journal of Cardio-Thoracic Surgery, p. 1195-1202, 2020
- DOI for Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
- Download full text (pdf) of Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
-
Part of Upsala Journal of Medical Sciences, p. 325-329, 2020
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 2372-2382, 2020
- DOI for Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-177-Dotatate: an analysis of the NETTER-1 study
- Download full text (pdf) of Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-177-Dotatate: an analysis of the NETTER-1 study
-
Part of Annals of Oncology, p. 844-860, 2020
-
Neuroendocrine Neoplasms of the Small Bowel and Pancreas
Part of Neuroendocrinology, p. 444-476, 2020
-
Part of Neuroendocrinology, p. 185-197, 2020
-
Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome
Part of Journal of Patient-Reported Outcomes, 2019
- DOI for Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome
- Download full text (pdf) of Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome
-
Part of Endocrine Connections, p. 442-453, 2019
- DOI for NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging
- Download full text (pdf) of NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging
-
Part of The Oncologist, 2019
-
NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease
Part of Neuroendocrinology, p. 219-231, 2019
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms
Part of Endocrine, Metabolic & Immune Disorders - Drug Targets, p. 419-449, 2018
-
Part of Neuroendocrinology, p. 355-365, 2018
-
IFN-alpha in advanced well-differentiated neuroendocrine tumors: the neglected drug?
Part of Future Oncology, p. 897-899, 2018
-
The Genesis of the Neuroendocrine Tumors Concept: From Oberndorfer to 2018
Part of Endocrinology and metabolism clinics of North America (Print), p. 711-731, 2018
-
Part of Journal of Clinical Oncology, p. 2578-2584, 2018
-
Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome
Part of Clinical Therapeutics, p. 952-962, 2018
- DOI for Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome
- Download full text (pdf) of Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome
-
Is the EORTC QLQ-QNET21 Optimal for Patients with Neuroendocrine Tumors?
Part of Neuroendocrinology, p. 122-122, 2018
-
Part of Neuroendocrinology, p. 260-260, 2018
-
Weight Change Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome
Part of Pancreas, p. 357-358, 2018
-
Part of Pancreas, p. 341-342, 2018
-
Part of Pancreas, p. 355-355, 2018
-
Part of JAMA Oncology, p. 183-189, 2018
-
Evaluation of meaningful change in bowel move frequency for patients with carcinoid syndrome
Part of Oncology Research and Treatment, p. 238-238, 2017
-
Part of Journal of global oncology, p. 43-53, 2017
- DOI for Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs
- Download full text (pdf) of Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs
-
Part of Neuroendocrinology, p. 54-66, 2017
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017
-
Part of Annals of Oncology, 2017
-
Part of Annals of Oncology, 2017
-
Long-term survival of patients with carcinoid syndrome in clinical trials of telotristat ethyl
Part of Annals of Oncology, 2017
-
Part of Neuroendocrinology, p. 212-212, 2017
-
Part of Neuroendocrinology, p. 257-257, 2017
-
Part of The Lancet Oncology, p. 1652-1664, 2017
-
Part of Clinical Therapeutics, p. 2158-2168, 2017
- DOI for Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat Ethyl
- Download full text (pdf) of Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat Ethyl
-
Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors
Part of New England Journal of Medicine, p. 125-135, 2017
-
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
Part of Neuroendocrinology, p. 201-211, 2017
-
Part of Annals of Oncology, p. 1569-1575, 2017
-
Part of Pancreas, p. 434-435, 2017
-
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome
Part of Journal of Clinical Oncology, p. 14-23, 2017
-
Part of Annals of Oncology, 2016
-
Part of Annals of Oncology, 2016
-
Part of Pancreas, p. 470-470, 2016
-
Part of Pancreas, p. 478-478, 2016
-
Part of Neuroendocrinology, p. 95-95, 2016
-
Part of Neuroendocrinology, p. 89-89, 2016
-
Part of Neuroendocrinology, p. 88-88, 2016
-
Part of Neuroendocrinology, p. 115-115, 2016
-
Part of Endocrine Connections, p. 174-187, 2016
- DOI for A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
- Download full text (pdf) of A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
-
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
Part of ESMO Open, 2016
- DOI for ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
- Download full text (pdf) of ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016
-
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Part of Neuroendocrinology, p. 125-138, 2016
-
Part of Neuroendocrinology, p. 144-152, 2016
-
Part of Journal of Clinical Oncology, p. 3906-3913, 2016
-
Part of Neuroendocrinology, p. 172-185, 2016
-
Part of Pancreas, p. 483-483, 2016
-
Part of Annals of Oncology, p. 121-121, 2016
-
Part of Annals of Oncology, 2016
-
Part of Journal of Clinical Oncology, 2016
-
Universal everolimus for malignant neuroendocrine tumours?
Part of The Lancet, p. 924-926, 2016
-
Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs
Part of PLOS ONE, 2015
- DOI for Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs
- Download full text (pdf) of Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs
-
Part of Pancreas, p. 359-359, 2015
-
Part of Drug Design, Development and Therapy, p. 5075-5086, 2015
- DOI for Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
- Download full text (pdf) of Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
-
Part of Neuroendocrinology, p. 211-222, 2015
-
Functional role of miR-196a in neuroendocrine tumor cells
Part of Neuroendocrinology, p. 87-87, 2015
-
Part of Neuroendocrinology, p. 18-25, 2015
-
Part of Annals of Oncology, p. 1604-1620, 2015
-
Roles of miR-196a on gene regulation of neuroendocrine tumor cells
Part of Molecular and Cellular Endocrinology, p. 131-139, 2015
-
Part of European Journal of Cancer, 2015
-
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects
Part of Neuroendocrinology, p. 274-288, 2015
-
Part of Neuroendocrinology, p. 159-160, 2015
-
Part of European Journal of Cancer, 2015
-
Part of Endocrine-Related Cancer, p. 933-940, 2015
- DOI for Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis
- Download full text (pdf) of Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis
-
Part of Pancreas, p. 508-509, 2014
-
Part of Pancreas, p. 508-508, 2014
-
Treatment of high-grade neuroendocrine tumors beyond platinum/etoposide
Part of Oncology Research and Treatment, p. 297-298, 2014
-
Indication for Liver Transplantation in Young Patients with Small Intestinal NETs Is Rare?
Part of World Journal of Surgery, p. 742-747, 2014
-
2014
-
Neuroendocrine Tumor Biomarkers: Current Status and Perspectives
Part of Neuroendocrinology, p. 265-277, 2014
-
Part of Journal of Endocrinological Investigation, p. 875-909, 2014
-
Part of Neuroendocrinology, p. 63-74, 2014
-
Part of Neuroendocrinology, p. 280-281, 2014
-
Part of Neuroendocrinology, p. 274-274, 2014
-
Part of Neuroendocrinology, p. 228-228, 2014
-
Part of Journal of Clinical Oncology, 2014
-
Part of PLOS ONE, 2013
- DOI for Identification of Candidate Serum Proteins for Classifying Well-Differentiated Small Intestinal Neuroendocrine Tumors
- Download full text (pdf) of Identification of Candidate Serum Proteins for Classifying Well-Differentiated Small Intestinal Neuroendocrine Tumors
-
Part of European Journal of Endocrinology, p. 253-261, 2013
-
Part of Therapeutic Advances in Gastroenterology, p. 412-419, 2013
-
Effect of Temozolomide in Patients with Metastatic Bronchial Carcinoids
Part of Neuroendocrinology, p. 151-155, 2013
-
Part of Lung Cancer, p. 289-293, 2013
-
Part of Journal of Molecular Endocrinology, p. 277-286, 2013
-
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
Part of Modern Pathology, p. 685-696, 2013
-
Part of Pancreas, p. 373-373, 2013
-
Part of Pancreas, p. 377-377, 2013
-
Part of European Journal of Cancer, 2013
-
Part of Neuroendocrinology, p. 16-30, 2013
-
Part of Pancreas, p. 369-370, 2013
-
Neuroendocrine tumours in 2012: Insights into signalling pathways could individualize therapy
Part of Nature reviews. Endocrinology, p. 70-72, 2013
-
Part of Endocrine, p. 3-4, 2012
-
The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells
Part of PLOS ONE, 2012
- DOI for The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells
- Download full text (pdf) of The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells
-
Part of Acta Oncologica, p. 124-127, 2012
-
Part of World Journal of Surgery, p. 1419-1431, 2012
-
The Management of Neuroendocrine Tumours: Current and Future Medical Therapy Options
Part of Clinical Oncology, p. 282-293, 2012
-
Unusual Complication of a Pancreatic Neuroendocrine Tumor Presenting with Malignant Hypercalcemia
Part of Journal of Clinical Endocrinology and Metabolism, 2012
-
Part of Neuroendocrinology, p. 157-176, 2012
-
Implications for clinical practice and trial design
Part of Annals of Oncology, p. 47-48, 2012
-
Part of Annals of Oncology, 2012
-
Part of Annals of Oncology, 2012
-
Part of Regulatory Peptides, 2012
-
Part of Annals of Oncology, p. 377-377, 2012
-
Part of Baillière's Best Practice & Research, p. 833-841, 2012
-
Part of Cancers, p. 100-112, 2012
-
Part of Endocrine-related cancer, p. 657-66, 2012
-
Part of ANTI-CANCER AGENT ME, p. 783-790, 2012
-
Gastric carcinoid in a patient infected with Helicobacter pylori: A new entity?
Part of World Journal of Gastroenterology, p. 3066-3068, 2011
-
Advances in Pancreatic Neuroendocrine Tumor Treatment REPLY
Part of New England Journal of Medicine, p. 1874-1875, 2011
-
Management of Advanced Small Intestinal Neuroendocrine Tumors
Part of European journal of clinical & medical oncology, p. 64-70, 2011
-
Part of Hormone and Metabolic Research, p. 823-824, 2011
-
Neuroendocrine tumors A growing cancer field
Part of Revista Portuguesa de Cirurgia, p. 23-24, 2011
-
Part of Cancer, p. 4617-4622, 2011
-
Management of neuroendocrine tumors: Current and future therapies
Part of Expert Reviews Endocrinology & Metabolism, p. 49-62, 2011
-
Neuroendocrine tumors: recent progress in diagnosis and treatment
Part of Endocrine-Related Cancer, 2011
-
Part of Journal of Clinical Oncology, p. 934-943, 2011
-
Everolimus for advanced pancreatic neuroendocrine tumors
Part of New England Journal of Medicine, p. 514-523, 2011
-
Part of Gene Therapy, p. 1052-1062, 2011
-
Part of Endocrine-Related Cancer, p. 171-180, 2011
-
Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours
Part of Endocrine-Related Cancer, 2011
-
Part of Journal of Clinical Endocrinology and Metabolism, p. 3741-3749, 2011
-
Part of The Lancet, p. 2005-2012, 2011
-
Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management.
Part of Medical Journal of Australia, p. 46-52, 2010
-
Part of NET Journal Club, 2010
-
Part of Annals of Oncology, 2010
-
ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors
Part of Neuroendocrinology, p. 341-350, 2010
-
Cancer: antitumor effects of octreotide LAR, a somatostatin analog
Part of Nature reviews. Endocrinology, p. 188-189, 2010
-
Part of PLOS ONE, 2010
-
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
Part of Acta Oncologica, p. 740-756, 2010
-
90Y-edotreotide for metastatic carcinoid refractory to octreotide
Part of Journal of Clinical Oncology, p. 1652-1659, 2010
-
Part of Pancreas, p. 784-798, 2010
-
Part of Neuroendocrinology, p. 326-332, 2010
-
Part of American Journal of Surgical Pathology, p. 300-313, 2010
-
The history and development of the gastroenteropancreatic endocrine axis
Part of Endocrinology and metabolism clinics of North America (Print), p. 697-711, 2010
-
Neuroendokrine tumorer: ny diagnostik og terapi
Part of Ugeskrift for laeger, p. 2941-2941, 2010
-
Part of Treatment Strategies - Oncology, p. 150-156, 2010
-
Neuroendocrine tumors (NETs): historical overview and epidemiology
Part of Tumori (Milano), p. 797-801, 2010
-
Rationale for Combining mTOR with other Targeted Agents in the Treatment of Neuroendocrine Tumors
Part of Neuroendocrinology, p. 49-50, 2010
-
Part of Anticancer Research, p. 149-156, 2010
-
Gastrointestinal neuroendocrine tumors
Part of Annals of Oncology, 2010
-
Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®)
Part of Acta Oncologica, p. 100-101, 2010
-
Part of PLOS ONE, 2010
- DOI for Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors
- Download full text (pdf) of Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors
-
Part of Neuroendocrinology, p. 42-43, 2010
-
Part of Annals of Oncology, p. 266-266, 2010
-
Part of Annals of Oncology, 2010
-
Part of Acta Oncologica, p. 391-400, 2009
- DOI for Midgut carcinoid patients display increased numbers of regulatory T cells in peripheral blood with infiltration into tumor tissue
- Download full text (pdf) of Midgut carcinoid patients display increased numbers of regulatory T cells in peripheral blood with infiltration into tumor tissue
-
Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas
Part of Modern Pathology, p. 261-272, 2009
-
Is It Time to Widen the Use of Somatostatin Analogs in Neuroendocrine Tumors?
Part of Journal of Clinical Oncology, p. 4635-4636, 2009
-
Part of Current Opinion in Endocrinology, Diabetes and Obesity, p. 72-78, 2009
-
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy
Part of Neuroendocrinology, p. 209-213, 2009
-
Part of Neuroendocrinology, p. 167-183, 2009
-
Part of Annals of Oncology, p. 147-149, 2009
-
Part of Annals of Oncology, p. 150-153, 2009
-
Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines
Part of Cancer Chemotherapy and Pharmacology, p. 5-12, 2009
-
Part of Neuroendocrinology, p. 302-307, 2009
-
Part of Cancer Immunology and Immunotherapy, p. 399-409, 2008
-
Selective internal radiation therapy in patients with carcinoid liver metastases
Part of Acta Oncologica, p. 1169-1171, 2008
-
Management of neuroendocrine tumors: a meeting of experts from Latin America
Part of Neuroendocrinology, p. 235-42, 2008
-
Poorly-differentiated endocrine carcinomas of midgut and hindgut origin
Part of Neuroendocrinology, p. 40-46, 2008
-
Part of Neuroendocrinology, p. 53-8, 2008
-
Part of Annals of Oncology, p. 104-105, 2008
-
Part of Annals of Oncology, p. 102-103, 2008
-
Regression of a large malignant gastrinoma on treatment with Sandostatin LAR: a case report
Part of Digestion, p. 92-5, 2008
-
Part of Medical Oncology, p. 330-337, 2007
-
Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors
Part of Clinical Cancer Research, p. 2986-2991, 2007
-
Part of Acta Radiologica, p. 180-185, 2007
-
Part of Regulatory Peptides, p. 1-9, 2007
-
Expression and function of vinculin in neuroendocrine tumors
Part of Tumor Biology, p. 196-204, 2007
-
A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy
Part of Clinical Cancer Research, p. 2455-2462, 2007
-
Somatostatin induces rapid contraction of neuroendocrine cells
Part of FEBS Letters, p. 1957-1962, 2007
-
Clinical management of neuroendocrine GEP-tumors - Current concepts and future directions
Part of Medicinska Istrazivanja: The Journal of the School of Medicine University of Belgrade, p. 24-27, 2007
-
Lungcarcinoider: inte så benigna som man trott
Part of Läkartidningen, p. 2382-2384, 2006
-
Well-differentiated pancreatic tumor/carcinoma: insulinoma
Part of Neuroendocrinology, p. 183-188, 2006
-
Well-differentiated pancreatic nonfunctioning tumors/carcinoma
Part of Neuroendocrinology, p. 196-211, 2006
-
Part of Anticancer Research, p. 4125-4129, 2006
-
Part of Virchows Arch, p. 1-8, 2006
-
Expression of tyrosine kinase receptors in lung carcinoids.
Part of Tumour Biol, p. 153-7, 2006
-
Molecular imaging in diagnosis of neuroendocrine tumours.
Part of Lancet Oncol, p. 790-2, 2006
-
Part of Annals of the New York Academy of Sciences: Pheochromocytoma: First International Symposium, p. 59-78, 2006
-
Major Coverage of the advances in an expanding field
Part of Expert Review of Endocrinology & Metabolism, p. 1-2, 2006
-
Part of Journal of Clinical Endocrinology and Metabolism, p. 3392-3400, 2005
-
Developments in PET for the detection of endocrine tumours
Part of Baillière's Best Practice & Research. Clinical Endocrinology & Metabolism, p. 311-324, 2005
-
Gene expression in midgut carcinoid tumors: potential targets for immunotherapy
Part of Acta Oncologica, p. 32-40, 2005
-
Part of Neuroendocrinology, p. 264-73, 2005
-
A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B.
Part of Regul Pept, p. 193-9, 2005
-
Part of Curr Opin Oncol, p. 386-91, 2005
-
Business Briefing: European oncology review
Part of Business Briefing: European oncology review, 2005
-
Part of Rocz Akad Med Bialymst, p. 62-8, 2005
-
Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours
Part of Best Practice & Research Clinical Endocrinology & Metabolism, p. 265-276, 2005
-
Part of European Journal of Endocrinology, p. 107-112, 2004
-
PET in the diagnosis of neuroendocrine tumors
Part of Annals of the New York Academy of Sciences, p. 246-257, 2004
-
Part of Med Oncol, p. 285-96, 2004
-
A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A.
Part of Regul Pept, p. 219-27, 2004
-
Part of Acta Oncol, p. 626-36, 2004
-
Management of neuroendocrine tumours.
Part of Ann Oncol, 2004
-
Future aspects of somatostatin-receptor-mediated therapy.
Part of Neuroendocrinology, p. 57-61, 2004
-
Part of The journal of clinical endocrinology & metabolism, p. 2326-2337, 2004
-
Part of Ann Oncol, p. 966-73, 2004
-
Part of Acta Oncol, p. 617-25, 2004
-
Part of Medical Oncology, p. 59-67, 2003
-
Part of Med Oncol, p. 59, 2003
-
Octreoscan in patients with bronchial carcinoid tumours.
Part of Clin Endocrinol (Oxf), p. 793-9, 2003
-
Part of J Natl Cancer Inst, p. 437-48, 2003
-
Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
Part of Cancer Chemother Biol Response Modif, p. 535-46, 2003
-
Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1).
Part of Fam Cancer, p. 27-33, 2003
-
Part of Anticancer Research, p. 2227-2232, 2003
-
The role of PET in localization of neuroendocrine and adrenocortical tumors
Part of Annals of the New York Academy of Sciences, p. 159-169, 2002
-
Part of European Journal of Cancer Care, p. 91-99, 2002
-
Tractor-driving hours and their relation to self-reported low-back and hip symptoms.
Part of Appl Ergon, p. 139-46, 2002
-
Part of Med Oncol, p. 151, 2002
-
Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
Part of World J Surg, p. 991, 2002
-
Part of Med Oncol, p. 35-42, 2002
-
Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment.
Part of Curr Opin Oncol, p. 38-45, 2002
-
Part of Cancer Invest, p. 348, 2002
-
Experience in treatment of metastatic pulmonary carcinoid tumors
Part of Annals of Oncology, p. 1383-1391, 2001
-
Part of Biochem Biophys Res Commun, p. 227-31, 2001
-
Treatment with Cisplatin and Etoposide in Patients with Neuroendocrine Tumors
Part of Cancer, p. 1101-1107, 2001
-
Part of Endocrinology, p. 477, 2001
-
Chemotherapy and biotherapy in the treatment of neuroendocrine tumours.
Part of Ann Oncol, 2001
-
Standardisation of imaging in neuroendocrine tumours: results of a European delphi process.
Part of Eur J Radiol, p. 8-17, 2001
-
Use of PET in neuroendocrine tumors: In vivo applications and in vitro studies
Part of The Quarterly journal of nuclear medicine, p. 68-76, 2000
-
Subcellular distribution of phospholipase C isoforms in rodent pancreas and gastric mucosa
Part of Endocrinology, p. 2589-2593, 2000
-
Subcellular distribution of phospholipase C isoforms in rodent pancreas and gastric mucosa.
Part of Endocrinology, p. 2589-93, 2000
-
Part of J Nuclear Medicine, p. 1514, 2000
-
Part of J Endocrinol, p. 315, 2000
-
Part of Annals of Oncology, p. 1321-1327, 1999
-
Positron emission tomography in neuroendocrine tumours
Part of The Italian Journal of Gastroenterology and Hepatology, 1999
-
Plasma Chromogranin A In Patients with Multiple Endocrine Neoplasia Type 1
Part of Journal of Clinical Endocrinology and Metabolism, p. 2712-2717, 1999
-
In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complex
Part of Acta Oncol., p. 383, 1999
-
Tumour markers in neuroendocrine tumours
Part of Ital J Gastroenterol Hepatol, p. 160, 1999
-
Somatostatin receptor ligands and their use in the treatment of endocrine disorders
Part of Curr Pharm Des, p. 693, 1999
-
Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinid disease
Part of J Gastroenterol Hepatol, p. 500-507, 1999
-
Targeted disruption of the mouse phospholipase C β3 gene results in early embryonic lethality
Part of FEBS Letters, p. 261-265, 1998
-
Part of World Journal of Surgery, p. 673-677; discussion 667-668, 1998
-
[PET in neuroendocrine tumors].
Part of Nordisk Medicin, p. 308-312, 1998
-
Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids
Part of Gut, p. 223-228, 1998
-
Part of Cancer Res, p. 2375-8, 1998
-
Part of Eur J Cancer, p. 2046, 1998
-
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center
Part of Annals of Oncology, p. 685-690, 1997
-
Part of Acta Oncol., p. 60714, 1997
-
Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors
Part of World J Surg, p. 900, 1996
-
Part of Digestion, p. 77, 1996
-
Part of Cancer Research, p. 2561, 1996
-
Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours
Part of Regulatory Peptides, p. 119-131, 1995
-
Part of Cancer Research, p. 5801, 1995
-
Multiple endocrine neoplasia type 1. Clinical features and screening.
Part of Endocrinol Metab Clin North Am, p. 1-18, 1994
-
Expression of transforming growth factor b1, b2, b3 in neuroendocrine tumors of the digestive system
Part of Anticancer Res, p. 2085, 1994
-
Part of Diabetologia, p. 843-9, 1993
-
Part of J Endocrinol, p. 329-37, 1993
-
Part of Scand. J. Gastroenterol, p. 155-159, 1992
-
Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours.
Part of Lancet, p. 337-40, 1990
-
[New medical therapy of neuroendocrine gastrointestinal tumors]
Part of Lakartidningen, p. 2668-72, 1990
Articles, review/survey
-
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
Part of European Journal of Cancer, p. 56-73, 2021
-
Part of Neuroendocrinology, p. 609-630, 2021
-
A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood
Part of Annals of Oncology, p. 202-212, 2020
-
Part of The Lancet Oncology, 2020
-
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
Part of Advances in Medical Sciences, p. 18-29, 2020
- DOI for The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
- Download full text (pdf) of The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
-
Part of Neuroendocrinology, p. 198-216, 2020
-
Part of Therapeutic Advances in Gastroenterology, 2018
- DOI for Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift
- Download full text (pdf) of Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift
-
Management of functional neuroendocrine tumors of the pancreas
Part of Gland surgery, p. 20-27, 2018
-
Medical Therapy of Gastrointestinal Neuroendocrine Tumors
Part of Visceral Medicine, p. 352-356, 2017
-
Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms.
Part of Nature Reviews Clinical Oncology, p. 691-705, 2016
-
Part of Endocrine-Related Cancer, 2016
-
Part of Scandinavian Journal of Gastroenterology, p. 727-739, 2015
-
Consensus on biomarkers for neuroendocrine tumour disease
Part of The Lancet Oncology, 2015
-
Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment
Part of Endocrine-Related Cancer, 2014
-
Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges
Part of Cancer Metastasis Review, p. 353-359, 2014
-
Part of Clinical Cancer Research, p. 2842-2849, 2013
-
The genetics of neuroendocrine tumors
Part of Seminars in Oncology, p. 37-44, 2013
-
Part of Theranostics, p. 448-458, 2012
-
Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors
Part of Clinics, p. 109-112, 2012
-
Part of Current Opinion in Oncology, 2012
-
Part of Pancreatic Disorders & Therapy, 2012
-
Somatostatin analogs for the treatment of neuroendocrine tumors
Part of Cancer Metastasis Review, p. 9-17, 2011
-
Current knowledge on diagnosis and staging of neuroendocrine tumors
Part of Cancer Metastasis Review, p. 3-7, 2011
-
Oncolytic Viruses for the Treatment of Neuroendocrine Tumors
Part of Hormone and Metabolic Research, p. 877-883, 2011
-
Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors
Part of Hormone and Metabolic Research, p. 832-837, 2011
-
Part of Seminars in Oncology, p. 594-618, 2010
-
Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy
Part of Gastroenterology, p. 742-753, 753.e1, 2010
-
Somatostatin analog octreotide LAR® in gastro–entero–pancreatic tumors
Part of Expert review of anticancer therapy, p. 557-566, 2009
-
Gastroenteropancreatic neuroendocrine tumours
Part of The Lancet Oncology, p. 61-72, 2008
-
Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors
Part of Endocrine-Related Cancer, p. 221-232, 2007
-
Part of Annals of Oncology, p. 13-19, 2007
-
The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1.
Part of J Intern Med, p. 471-6, 1998
Books
Chapters in book
-
The NETest: A Multigene Liquid Biopsy for Diagnosis and Management of Neuroendocrine Tumors
Part of Neuroendocrine Tumours Diagnosis and Management, p. 81-102, Springer, 2024
-
Societies and Guidelines for Neuroendocrine Tumors
Part of Neuroendocrine Tumours Diagnosis and Management, p. 677-682, Springer, 2024
-
Update of Neuroendocrine Tumors, Diagnosis, and Management
Part of Neuroendocrine Tumours, p. 175-183, Springer, 2024
-
Imaging of Neuroendocrine Tumors
Part of Imaging in Endocrine Disorders, p. 142-151, Karger, 2016
-
Imaging of Neuroendocrine Tumors
Part of Imaging in Endocrine Disorders, p. 142-151, S. Karger, 2016
-
Tumores Neuroendocrinos Gastrointestinais:
Part of Aparelho Digestivo Clinica e Cirurgia, p. 337, Atheneu, 2012
-
Which therapy for which patient?
Part of Advances in neuroendocrine tumor management, p. 64-70, Future Medicine, 2011
-
Treatment strategies in neuroendocrine tumours:
Part of Treatment Strategies Oncology, p. 117-119, Cambridge Research Centre, 2011
-
Chapter 6, Diagnostic pathways:
Part of Handbook of Gastroenteropancreatic and thoracic neuroendocrine tumours, Bioscientifica, 2010
-
Part of Management of Rare Adult Tumours, p. 539-550, Springer, 2010
-
Receptor Ligands: Somatostatin analogs
Part of Bioactive Peptides, p. 169-187, CRC Press, 2009
-
Part of Update on Cancer Therapeutics 2, p. 41-52, Elsevier, Oxford, 2007
-
Part of Hematology-oncology therapy, p. 72-79, McGraw-Hill, 2007
-
Rectal neuroendocrine tumors: Diagnosis and treatment
Part of A Century of Advances in Neuroendocrine tumor biology and treatment, p. 124-133, Felsenstein, 2007
-
Non-functioning pancreatic endocrine tumors
Part of A Century of Advances in Neuroendocrine tumor biology and treatment, p. 86-99, Felsenstein, 2007
-
Carcinoid tumors - current considerations
Part of A Century of Advances in Neuroendocrine tumor biology and treatment, p. 40-53, Felsenstein, 2007
-
Summation Session Section II: Neuroendocrine cell biology
Part of A Century of Advances in Neuroendocrine tumor biology and treatment, 2007
-
Carcinoid tumors, carcinoid syndrome and related disorders
Part of Williams Textbook of Endocrinology. 11th edition, p. 1821-1840, Saunders Elsevier, 2007
-
Part of Internmedicin 4th ed, p. 681-687, Liber, Stockholm, 2006
-
The role of radiopharmaceuticals in diagnosis of neuroendocrine tumors
Part of 2006 ASCO Educational Book, ASCO, Virginia, 2006
-
Part of Neuroendocrine Tumors Handbook, BioScientifica, 2006
-
Part of Gastroenterology and Hepatology: the Modern Clinician's Guide, p. 823-830, Weinstein WM, Hawkey CJ and Bosch J, 2005
-
Diseases of the gut and liver: The carcinoid syndrome
Part of Clinical Gastroenterology and Hepatology, p. 823, Elsevier Mosby, 2005
-
Part of Endocrinology, Elsevier, 2005
-
Somatostatin analogue therapy of neuro-endocrine gastro-entero pancreatic tumors
Part of Somatostatin, p. 251-270, Kluwer Academic Publishers, 2004
-
PET for clinical diagnosis and research in neuroendocrine tumors
Part of Diagn Nuclear Medicine 4th edition, p. 747-754, 2003
-
Part of Tumor markers, p. 339-349, 2002
-
Carcinoid tumors, carcinoid syndrome and related disorders
Part of Williams Textbook of Endocrinology. 10th edition, p. 1857-1876, Saunders, 2002
-
Malignant neuroendocrine tumors.
Part of Cancer Chemother Biol Response Modif, p. 463, 2002
-
Neuroendocrine tumors: New perspection in their therapy
Part of Advances in pancreatic disease, p. 376-96, Georg Thieme Verlag Stuttgart, New York, 2000
-
Part of Clinical Gastroenterology, 1996
-
Clinical GastroenterologyCarcinoid tumours.
1996
Collections (editor)
-
Advances in Neuroendocrine Tumor Management
Future Medicine Ltd, 2011
-
Advances in Neuroendocrine Tumor Management
Future Medicine Ltd, 2011
-
Elsevier, 2007
Conference papers
-
Nordic and North American neuro endocrine tumor management: A clinical and scientific synopsis
2008
-
Interferon: Does it still play a role?
2007
-
Treatment of neuroendocrine tumours of the gastrointestinal tract
Part of III Interdisciplinary Course on Oncology, 2004
Other
-
How does PROMID change the treatment landscape of NET
2010
-
Part of Cancer Chemother Biol Response Modif, p. 471-83, 2005
-
Neuroendocrine GEP Tumors-Recent update on diagnosis and treatment
2005
-
Neuroendocrine tumors-Somatostatin receptors and treatment
Part of Austral-Asian Journal of Cancer, p. 51-59, 2004
-
The role of the somatostatin analogues
Part of NETnews, 2004
-
Tumor markers in neuroendocrine gastrointestinal tumors
2004